AA
ANIK icon

ALPS Advisors’s Anika Therapeutics ANIK Stock Holding History

ALPS Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27,512
Closed -$1.51M – 818
2019
Q3 		$1.51M Sell
27,512
-2,223
-7% -$114K 0.01% 242
2019
Q2 		$1.21M Buy
+29,735
New +$1.08M 0.01% 289
2018
Q1 		– Sell
-8,398
Closed -$453K – 871
2017
Q4 		$453K Hold
8,398
– – ﹤0.01% 639
2017
Q3 		$487K Buy
+8,398
New +$439K ﹤0.01% 572
2017
Q1 		– Sell
-8,849
Closed -$433K – 737
2016
Q4 		$433K Sell
8,849
-116
-1% -$5.36K ﹤0.01% 532
2016
Q3 		$429K Buy
+8,965
New +$443K ﹤0.01% 414
2016
Q1 		– Sell
-14,012
Closed -$535K – 639
2015
Q4 		$535K Hold
14,012
– – 0.01% 361
2015
Q3 		$446K Buy
14,012
+778
+6% +$27.1K ﹤0.01% 591
2015
Q2 		$437K Buy
13,234
+206
+2% +$7.35K ﹤0.01% 609
2015
Q1 		$536K Buy
13,028
+404
+3% +$16.3K ﹤0.01% 352
2014
Q4 		$514K Sell
12,624
-1,792
-12% -$70K ﹤0.01% 448
2014
Q3 		$528K Buy
14,416
+580
+4% +$25.1K ﹤0.01% 551
2014
Q2 		$641K Buy
13,836
+352
+3% +$15.7K 0.01% 294
2014
Q1 		$554K Sell
13,484
-6,922
-34% -$257K 0.01% 493
2013
Q4 		$679K Buy
20,406
+9,878
+94% +$305K 0.01% 161
2013
Q3 		$252K Buy
+10,528
New +$236K ﹤0.01% 377

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ALPS Advisors's ANIK Position: Q4 2019 in Review

ALPS Advisors sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 27,512 shares — an estimated $1.51M sold.

ALPS Advisors first reported a position in ANIK in Q3 2013 and held it in 16 quarters. The position peaked at $1.51M in Q3 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • ALPS Advisors reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • ALPS Advisors sold 27,512 Anika Therapeutics shares in Q4 2019, an estimated $1.51M.
  • ALPS Advisors first reported a position in Anika Therapeutics in Q3 2013 and held it in 16 quarters.
  • ALPS Advisors's Anika Therapeutics position peaked at $1.51M in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on ALPS Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.